Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Furosemide, Heparin, Hypertonic Saline in Mechanically Ventilated ARDS Adult Patients
NCT07286409Not yet recruiting
- Sponsor
- Tanta University
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Randomised trial of furosemide, heparin and hypertonic saline in acute respiratory distress syndrome (ARDS) (4 arms), sponsored by Tanta University. Primary endpoint: Murray Lung Injury Score at 7 days. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
furosemideheparinhypertonic saline
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT07286409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07286409.